Why it may matterVerify against the original reporting
The quarter shows a sharp year-over-year revenue drop and a sizable net loss, driven by a 59% drop in conventional egg prices and weak overall shell-egg pricing. While diversification and capacity plans may improve profitability over the cycle, the immediate earnings backdrop is negative, likely depressing CALM shares in the near term unless a rebound in conventional pricing or stronger prepared foods contributions materialize quickly.
AI summary
What happened, with direct paths to the underlying reporting
Cal-Maine reported a challenging Q1 2027 with net sales of $539.6 million, a 41.5% year-over-year decline and a $58.6 million net loss. The company is pushing diversification, with Specialty Shell Eggs and Prepared Foods comprising about 54% of sales and capacity expansions aimed at mid-FY2028. Key questions remain around the timing of conventional egg-market rebalancing and earnings from new segments.
CALM Q1 2027 net sales $539.6M, down 41.5% YoY. Net loss $58.6M.
Prepared Foods 11.7% of net sales; Specialty+Prepared now 54.1% of sales.
Acquired Eggland’s Best territory in Northeast; expands distribution footprint.
Capacity expansion: Prepared Foods capacity up >60% by H1 FY2028; no dividend.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
StoneX downgraded Cal-Maine Foods (CALM) to Hold, signaling a cautious near-term outlook as CALM traded around $76.03 on Thursday. The downgrade could pressure sentiment and promp…
Cal-Maine Foods reported a surprise fiscal fourth-quarter loss as historically low egg prices squeezed revenue and margins. The result underscores continued earnings sensitivity t…
